A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
Clinical trial NCT03962010 · UNKNOWN
Trial details
- NCT number
- NCT03962010
- Sponsor
- Genexine, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2022-06-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.